Please assess the completion status of the following clinical trial:

Trial Title: Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is \>= 18 years of age~* Subject had a clinical diagnosis of chronic plaque psoriasis for at least 6 months, and has moderate to severe plaque psoriasis~* Subject must have been treated and failed to respond to, or has a contraindication to, or is intolerant to at least two different systemic therapies, one of which must be cyclosporine, or methotrexate or oral PUVA~* Subject is judged to be in generally good health as determined by the principal investigator~Exclusion Criteria:~* Subject has previous exposure to adalimumab~* Subject cannot discontinue systemic therapies and/or topical therapies for the treatment of psoriasis and cannot avoid UVB or PUVA phototherapy~* Subject is taking or requires oral or injectible corticosteroids~* Subject diagnosed with erythrodermic psoriasis, pustular psoriasis, medication-induced or medication-exacerbated psoriasis or new onset guttate psoriasis~* Subject considered by the investigator, for any reason, to be an unsuitable candidate~* Female subject who is pregnant or breast-feeding or considering becoming pregnant~* Subject has a calcium metabolism disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- adalimumab + placebo (Type: ACTIVE_COMPARATOR): adalimumab + placebo (vehicle ointment)
- adalimumab + calcipotriol/betamethasone (Type: ACTIVE_COMPARATOR): adalimumab + calcipotriol/betamethasone ointment

Based on this trial design, predict the completion outcome and termination type (if applicable).